Overview

Compare Subjective Drug Liking & Pharmacokinetics of Vyvanse™ and ADDERALL XR® When Administered as an Oral Solution

Status:
Terminated
Trial end date:
2009-03-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare subjective drug liking using the Drug Rating Questionnaire, subject version (DRQ-S), question 2 and pharmacokinetics of Vyvanse™ and ADDERALL XR® when administered as an oral solution. Hypothesis: DRQ-S, question 2 will show no difference between the two drugs
Phase:
Phase 1
Details
Lead Sponsor:
Shire
Treatments:
Adderall
Dextroamphetamine
Lisdexamfetamine Dimesylate
Pharmaceutical Solutions